Paulus Stoffels
2013
In 2013, Paulus Stoffels earned a total compensation of $7.8M as Chief Scientific Officer; Worldwide Chair, Pharmaceuticals at Johnson & Johnson, a 7% increase compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $357,000 |
|---|---|
| Non-Equity Incentive Plan | $2,416,809 |
| Option Awards | $1,109,999 |
| Salary | $952,923 |
| Stock Awards | $2,580,468 |
| Other | $404,802 |
| Total | $7,822,001 |
Stoffels received $2.6M in stock awards, accounting for 33% of the total pay in 2013.
Stoffels also received $357K of change in pension value and nonqualified deferred compensation earnings, $2.4M in non-equity incentive plan, $1.1M in option awards, $952.9K in salary and $404.8K in other compensation.
Rankings
In 2013, Paulus Stoffels' compensation ranked 657th out of 12,286 executives tracked by ExecPay. In other words, Stoffels earned more than 94.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 657 out of 12,286 | 95th |
Division Manufacturing | 213 out of 4,614 | 95th |
Major group Chemicals And Allied Products | 54 out of 1,466 | 96th |
Industry group Drugs | 33 out of 1,160 | 97th |
Industry Pharmaceutical Preparations | 30 out of 890 | 97th |
Source: SEC filing on March 12, 2014.
Stoffels' colleagues
We found four more compensation records of executives who worked with Paulus Stoffels at Johnson & Johnson in 2013.